Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

LARIMAR THERAPEUTICS, INC. (LRMR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

LARIMAR THERAPEUTICS, INC. (LRMR), most recent 12 months reported: net loss $172.6M, free cash flow -$113.29M. Latest balance sheet on file: liquid cash $156.27M. From SEC filings. Others in Pharmaceutical Preparations: PASITHEA THERAPEUTICS CORP. · Lakewood-Amedex Biotherapeutics Inc. · LB PHARMACEUTICALS INC · Lite Strategy, Inc. · LANTERN PHARMA INC. · MAIA Biotechnology, Inc. · Veradermics, Inc · MUSTANG BIO, INC.

Stock screener

Watchlist